These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29150480)

  • 1. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.
    Rutter CM; Kim JJ; Meester RGS; Sprague BL; Burger EA; Zauber AG; Ergun MA; Campos NG; Doubeni CA; Trentham-Dietz A; Sy S; Alagoz O; Stout N; Lansdorp-Vogelaar I; Corley DA; Tosteson ANA
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):158-164. PubMed ID: 29150480
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimated US Cancer Deaths Prevented With Increased Use of Lung, Colorectal, Breast, and Cervical Cancer Screening.
    Knudsen AB; Trentham-Dietz A; Kim JJ; Mandelblatt JS; Meza R; Zauber AG; Castle PE; Feuer EJ
    JAMA Netw Open; 2023 Nov; 6(11):e2344698. PubMed ID: 37991759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
    Tosteson AN; Beaber EF; Tiro J; Kim J; McCarthy AM; Quinn VP; Doria-Rose VP; Wheeler CM; Barlow WE; Bronson M; Garcia M; Corley DA; Haas JS; Halm EA; Kamineni A; Rutter CM; Tosteson TD; Trentham-Dietz A; Weaver DL;
    J Gen Intern Med; 2016 Apr; 31(4):372-9. PubMed ID: 26658934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and provider characteristics associated with colorectal, breast, and cervical cancer screening among Asian Americans.
    Thompson CA; Gomez SL; Chan A; Chan JK; McClellan SR; Chung S; Olson C; Nimbal V; Palaniappan LP
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2208-17. PubMed ID: 25368396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark.
    Lee SJ; Boscardin WJ; Stijacic-Cenzer I; Conell-Price J; O'Brien S; Walter LC
    BMJ; 2013 Jan; 346():e8441. PubMed ID: 23299842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of cumulative colorectal cancer screening delays: A simulation study.
    Rutter CM; Inadomi JM; Maerzluft CE
    J Med Screen; 2022 Jun; 29(2):92-98. PubMed ID: 34894841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
    Charkhchi P; Schabath MB; Carlos RC
    J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer screening rates in individuals with different life expectancies.
    Royce TJ; Hendrix LH; Stokes WA; Allen IM; Chen RC
    JAMA Intern Med; 2014 Oct; 174(10):1558-65. PubMed ID: 25133746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.
    Barlow WE; Beaber EF; Geller BM; Kamineni A; Zheng Y; Haas JS; Chao CR; Rutter CM; Zauber AG; Sprague BL; Halm EA; Weaver DL; Chubak J; Doria-Rose VP; Kobrin S; Onega T; Quinn VP; Schapira MM; Tosteson ANA; Corley DA; Skinner CS; Schnall MD; Armstrong K; Wheeler CM; Silverberg MJ; Balasubramanian BA; Doubeni CA; McLerran D; Tiro JA
    J Natl Cancer Inst; 2020 Mar; 112(3):238-246. PubMed ID: 31292633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for cancer in low- and middle-income countries.
    Sankaranarayanan R
    Ann Glob Health; 2014; 80(5):412-7. PubMed ID: 25512156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.
    Trentham-Dietz A; Kerlikowske K; Stout NK; Miglioretti DL; Schechter CB; Ergun MA; van den Broek JJ; Alagoz O; Sprague BL; van Ravesteyn NT; Near AM; Gangnon RE; Hampton JM; Chandler Y; de Koning HJ; Mandelblatt JS; Tosteson AN;
    Ann Intern Med; 2016 Nov; 165(10):700-712. PubMed ID: 27548583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force.
    Knudsen AB; Rutter CM; Peterse EFP; Lietz AP; Seguin CL; Meester RGS; Perdue LA; Lin JS; Siegel RL; Doria-Rose VP; Feuer EJ; Zauber AG; Kuntz KM; Lansdorp-Vogelaar I
    JAMA; 2021 May; 325(19):1998-2011. PubMed ID: 34003219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
    Bertaut A; Coudert J; Bengrine L; Dancourt V; Binquet C; Douvier S
    PLoS One; 2018; 13(6):e0198939. PubMed ID: 29927995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer screening estimates for U.S. metropolitan areas.
    Nelson DE; Bolen J; Marcus S; Wells HE; Meissner H
    Am J Prev Med; 2003 May; 24(4):301-9. PubMed ID: 12726867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013].
    Bao HL; Wang LH; Wang LM; Fang LW; Zhang M; Zhao ZP; Cong S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):208-212. PubMed ID: 29495207
    [No Abstract]   [Full Text] [Related]  

  • 17. Uptake of cancer screening among adults with disabilities in Flanders (Belgium).
    Kellen E; Nuyens C; Molleman C; Hoeck S
    J Med Screen; 2020 Mar; 27(1):48-51. PubMed ID: 31474187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
    Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
    Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of age in screening for cancer.
    Law MR; Morris JK; Wald NJ
    J Med Screen; 1999; 6(1):16-20. PubMed ID: 10321365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of health insurance coverage on breast, cervical, and colorectal cancer screening in rural primary care settings.
    Carney PA; O'Malley J; Buckley DI; Mori M; Lieberman DA; Fagnan LJ; Wallace J; Liu B; Morris C
    Cancer; 2012 Dec; 118(24):6217-25. PubMed ID: 22648383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.